BPIFA1 and chronic obstructive pulmonary disease: Understanding the regulation of SPLUNC1 by TLR2 signaling will help design novel therapeutic approaches to restore SPLUNC1 levels in hosts with allergic diseases and cigarette smoke-associated diseases (e.g., COPD) which exhibit impaired SPLUNC1 production [13,41].